EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Impact of Changes in Chlamydia Treatment Guidelines on Recurrent/Persistent Rectal Chlamydia trachomatis Infections

Mary Bridget Waters iD, Anjuli D Wagner, Tim W Menza, Anna Berzkalns, Lisa E Manhart iD, Christine M Khosropour

Open Forum Infectious Diseases · 01.08.2026 · 13 (8)

DOI: 10.1093/ofid/ofag484 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 11.08.2026. Verfasst von Mary Bridget Waters und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Washington, Seattle, Washington, USA. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institutes of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prior to 2021, the US Centers for Disease Control and Prevention (CDC) recommended either doxycycline or azithromycin as first-line treatments for Chlamydia trachomatis (CT). By 2016, there was evidence showing that doxycycline was more effective than azithromycin for the treatment of rectal CT. This motivated the Public Health—Seattle & King County Sexual Health Clinic to update their clinic's protocol to treat rectal CT with exclusively doxycycline in mid-2016. The CDC later recommended this in July 2021.

Methods

Leveraging health records from the clinic, we performed a controlled interrupted time series analysis to evaluate the impact of updated treatment guidelines at the clinic on recurrent/persistent (RP) rectal chlamydia (RP-CT) infections among men who have sex with men using RP rectal gonorrhea (RP-GC) as a control outcome. We also evaluated if there were patient demographic and behavioral correlates associated with receipt of azithromycin before and after the change in clinic guidelines.

Results

Our analysis revealed a significant relative trend change between RP-CT and RP-GC when comparing the period of full implementation to preimplementation, showing a 16.9% greater reduction in the quarterly trend of RP-CT cases compared to RP-GC cases. Self-identifying as White and with human immunodeficiency virus were positively associated with receiving azithromycin for treatment of rectal CT after the change in guidelines.

Conclusions

The significant reduction in the trend change for RP-CT versus RP-GC when comparing the fully implemented period of exclusive doxycycline to the preimplementation period demonstrates the impact of the new treatment guidelines in reducing incidence of RP-CT infections.

Schlagwörter

Stichwörter der Autor:innen

STI treatment guidelineschlamydiacontrolled interrupted time seriesdoxycyclinerectal chlamydia

Autor:innen und Institutionen

  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Public Health-Seattle & King County, HIV/STI/HCV Program, Seattle, Washington, USA.
  • Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Mary Bridget Waters, Lisa E Manhart

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • National Institutes of Allergy and Infectious Diseases

Zitieren

APA

Waters, M. B., Wagner, A. D., Menza, T. W., Berzkalns, A., Manhart, L. E., & Khosropour, C. M. (2026). Impact of Changes in Chlamydia Treatment Guidelines on Recurrent/Persistent Rectal Chlamydia trachomatis Infections. Open Forum Infectious Diseases, 13(8). https://doi.org/10.1093/ofid/ofag484

Vancouver

Waters MB, Wagner AD, Menza TW, Berzkalns A, Manhart LE, Khosropour CM. Impact of Changes in Chlamydia Treatment Guidelines on Recurrent/Persistent Rectal Chlamydia trachomatis Infections. Open Forum Infectious Diseases. 2026;13(8). doi:10.1093/ofid/ofag484

BibTeX
@article{Waters2026,
  author = {Waters, Mary Bridget and Wagner, Anjuli D and Menza, Tim W and Berzkalns, Anna and Manhart, Lisa E and Khosropour, Christine M},
  title = {Impact of Changes in Chlamydia Treatment Guidelines on Recurrent/Persistent Rectal Chlamydia trachomatis Infections},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {8},
  doi = {10.1093/ofid/ofag484}
}
Kostenlos starten →